Did Nader say that it was May/June when they are g
Post# of 148281
I think we may have receptor occupancy tests for at least part of the CD12 trial at the 700mg dose. Since receptor occupancy is simply amount of CCR5 vs. occupancy at a given dosage it might be possible to show receptor occupancy from those results if the COVID-19 CCR5 level is comparable or higher than HIV.